Elsevier journal Maturitas publishes position statement on breast cancer screening

Recommended by Dr. Michael White, Published on September 17th, 2014
Rate this post

PUBLIC RELEASE DATE:

17-Sep-2014

Contact: Greyling Peoples g.peoples@elsevier.com 31-204-853-323 Elsevier

Amsterdam, September 17, 2014 Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of breast cancer screening.

Breast cancer is the most prevalent cancer in women, with slightly more than ten percent developing the disease in Western countries. Mammography screening is a well-established method to detect breast cancer. However there are concerns about over diagnosis with population-based screening programmes. Some tumors grow so slowly that they will not threaten the health of women during their lifetime. The women will die from another cause and thus it is argued that these tumors should not have been treated. Treatments can be invasive and painful, have major side-effects, especially in those with significant co-morbidities. While this is easy from an epidemiological standpoint, it is a dilemma for the treating physician dealing with individual women. It is virtually impossible to make the diagnosis of breast cancer and to predict the future behavior of that tumor. Thus individualization is proposed so that women may be categorized into 'low to moderate' and 'high' risk based on familial risk and the first screening mammogram so that further screening can be tailored.

These and other recommendations presented in EMAS' position statement are published in the article, "EMAS Position statement: Individualized breast cancer screening versus population-based mammography screening programmes" by Herman Depypere, Joelle Desreux, Faustino R. Prez-Lpez, Iuliana Ceausu, C. Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Yvonne T. van der Schouw, Tommaso Simoncini, Florence Tremollieres and Margaret Rees (DOI: 10.1016/j.maturitas.2014.09.002) and is available online on ScienceDirect.

###

Notes for editors

Copies of this paper are available to credentialed journalists upon request; please contact Elsevier's Newsroom at newsroom@elsevier.com or +31 20 4853564

About European Menopause and Andropause Society (EMAS)

Originally posted here:

Elsevier journal Maturitas publishes position statement on breast cancer screening

Related Post

Word Count: 331

Comments are closed.


effects males of specialist testosterone low in
testosterone enanthate powder

what causes low testosterone levels in men